大麻素的基础科学:内源性大麻素系统与围术期及慢性疼痛医学
本文为叙述性综述,旨在概述大麻素的基础科学,包括内源性大麻素系统的发现与功能、大麻素的药理学,以及与围术期和慢性疼痛医学相关的未来研究与治疗开发方向。文章指出大麻植物含数百种化合物,通过结合特定受体及与多种蛋白相互作用产生生理反应,人体自身也产生类似大麻素的化合物参与调节正常和病理生理过程。随着大麻合法化格局演变,理解其科学基础对提供者和患者具有重要意义。
要点
- 内源性大麻素系统参与调节正常和病理生理过程。
- 大麻植物含数百种化合物,通过特定受体及多种蛋白产生生理效应。
- 需理解大麻素科学以指导围术期和慢性疼痛医学实践。
核心结论
- 理解大麻素的基础科学对围术期和慢性疼痛医学的提供者与患者具有重要意义。
研究设计与样本
- 叙述性综述,概述内源性大麻素系统的发现与功能、大麻素药理学及未来研究方向。
主要发现
- 大麻植物中已鉴定并分离出数百种化合物,通过结合特定受体和与多种蛋白相互作用引发多种生理反应。
- 人体自身产生类似大麻素的化合物,参与调节正常和病理生理过程。
临床怎么用
- 围术期和慢性疼痛医学提供者应了解大麻素的基础科学及其对患者的影响。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The cannabis plant has been used for centuries to manage the symptoms of various ailments including pain. Hundreds of chemical compounds have been identified and isolated from the plant and elicit a variety of physiological responses by binding to specific receptors and interacting with numerous other proteins. In addition, the body makes its own cannabinoid-like compounds that are integrally involved in modulating normal and pathophysiological processes. As the legal cannabis landscape continues to evolve within the United States and throughout the world, it is important to understand the rich science behind the effects of the plant and the implications for providers and patients. This narrative review aims to provide an overview of the basic science of the cannabinoids by describing the discovery and function of the endocannabinoid system, pharmacology of cannabinoids, and areas for future research and therapeutic development as they relate to perioperative and chronic pain medicine.
引用
- Sideris A, Lauzadis J, Kaczocha M, et al. The Basic Science of Cannabinoids. Anesth Analg. 2023. PMID: 38100799. doi:10.1213/ANE.0000000000006472
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。